MRI assessment of myocardial viability

Research output: Contribution to journalArticle

Abstract

In the presence of coronary artery disease, global left ventricular (LV) systolic function is a critical prognostic indicator. Because of enhanced therapy for myocardial infarction, more patients survive but are left with residual myocardial damage that predisposes them to developing CHF in the future. Although treatments for CHF are evolving, preventing and minimizing further deteriorations in LV function are paramount in this population. Distinguishing severe LV dysfunction caused by thinned, infarcted myocardium with fibrosis and scarring from that due to viable but dysfunctional myocardium from chronic hypoperfusion has significant implications for clinical management. In patients in whom noninvasive testing identifies viability, undergoing revascularization improves outcomes. Noninvasive imaging techniques used to assess viable myocardium are based on demonstrating the presence of one or more of the following features: (1) contractile reserve; (2) sufficient perfusion for the delivery of substrates and removal of metabolic byproducts; (3) intact myocyte membranes to maintain ionic/electrochemical gradients; and (4) preserved metabolism with generation of high-energy phosphates. While nuclear and dobutamine echocardiography have been widely used for viability assessment, cardiac magnetic resonance imaging (CMR) is increasingly becoming an accepted clinical tool, particularly in light of its high spatial resolution, intrinsic ability to image 3-dimensionally, and greater soft tissue differentiation. Moreover, the versatility of the technique potentially allows for the simultaneous assessment of regional wall motion, perfusion, and metabolism. An overview of the CMR techniques is presented.

Original languageEnglish (US)
Pages (from-to)11-19
Number of pages9
JournalSeminars in Ultrasound, CT and MRI
Volume27
Issue number1
DOIs
StatePublished - Feb 2006

Fingerprint

Myocardium
Left Ventricular Function
Perfusion
Magnetic Resonance Imaging
Dobutamine
Left Ventricular Dysfunction
Muscle Cells
Cicatrix
Echocardiography
Coronary Artery Disease
Fibrosis
Phosphates
Myocardial Infarction
Membranes
Therapeutics
Population

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Radiological and Ultrasound Technology

Cite this

MRI assessment of myocardial viability. / Schmidt, Andre; Wu, Katherine Chih-Ching.

In: Seminars in Ultrasound, CT and MRI, Vol. 27, No. 1, 02.2006, p. 11-19.

Research output: Contribution to journalArticle

@article{5a8436d1b89c480fb47d8b4b4153c5f2,
title = "MRI assessment of myocardial viability",
abstract = "In the presence of coronary artery disease, global left ventricular (LV) systolic function is a critical prognostic indicator. Because of enhanced therapy for myocardial infarction, more patients survive but are left with residual myocardial damage that predisposes them to developing CHF in the future. Although treatments for CHF are evolving, preventing and minimizing further deteriorations in LV function are paramount in this population. Distinguishing severe LV dysfunction caused by thinned, infarcted myocardium with fibrosis and scarring from that due to viable but dysfunctional myocardium from chronic hypoperfusion has significant implications for clinical management. In patients in whom noninvasive testing identifies viability, undergoing revascularization improves outcomes. Noninvasive imaging techniques used to assess viable myocardium are based on demonstrating the presence of one or more of the following features: (1) contractile reserve; (2) sufficient perfusion for the delivery of substrates and removal of metabolic byproducts; (3) intact myocyte membranes to maintain ionic/electrochemical gradients; and (4) preserved metabolism with generation of high-energy phosphates. While nuclear and dobutamine echocardiography have been widely used for viability assessment, cardiac magnetic resonance imaging (CMR) is increasingly becoming an accepted clinical tool, particularly in light of its high spatial resolution, intrinsic ability to image 3-dimensionally, and greater soft tissue differentiation. Moreover, the versatility of the technique potentially allows for the simultaneous assessment of regional wall motion, perfusion, and metabolism. An overview of the CMR techniques is presented.",
author = "Andre Schmidt and Wu, {Katherine Chih-Ching}",
year = "2006",
month = "2",
doi = "10.1053/j.sult.2005.11.001",
language = "English (US)",
volume = "27",
pages = "11--19",
journal = "Seminars in Ultrasound, CT and MRI",
issn = "0887-2171",
publisher = "W.B. Saunders Ltd",
number = "1",

}

TY - JOUR

T1 - MRI assessment of myocardial viability

AU - Schmidt, Andre

AU - Wu, Katherine Chih-Ching

PY - 2006/2

Y1 - 2006/2

N2 - In the presence of coronary artery disease, global left ventricular (LV) systolic function is a critical prognostic indicator. Because of enhanced therapy for myocardial infarction, more patients survive but are left with residual myocardial damage that predisposes them to developing CHF in the future. Although treatments for CHF are evolving, preventing and minimizing further deteriorations in LV function are paramount in this population. Distinguishing severe LV dysfunction caused by thinned, infarcted myocardium with fibrosis and scarring from that due to viable but dysfunctional myocardium from chronic hypoperfusion has significant implications for clinical management. In patients in whom noninvasive testing identifies viability, undergoing revascularization improves outcomes. Noninvasive imaging techniques used to assess viable myocardium are based on demonstrating the presence of one or more of the following features: (1) contractile reserve; (2) sufficient perfusion for the delivery of substrates and removal of metabolic byproducts; (3) intact myocyte membranes to maintain ionic/electrochemical gradients; and (4) preserved metabolism with generation of high-energy phosphates. While nuclear and dobutamine echocardiography have been widely used for viability assessment, cardiac magnetic resonance imaging (CMR) is increasingly becoming an accepted clinical tool, particularly in light of its high spatial resolution, intrinsic ability to image 3-dimensionally, and greater soft tissue differentiation. Moreover, the versatility of the technique potentially allows for the simultaneous assessment of regional wall motion, perfusion, and metabolism. An overview of the CMR techniques is presented.

AB - In the presence of coronary artery disease, global left ventricular (LV) systolic function is a critical prognostic indicator. Because of enhanced therapy for myocardial infarction, more patients survive but are left with residual myocardial damage that predisposes them to developing CHF in the future. Although treatments for CHF are evolving, preventing and minimizing further deteriorations in LV function are paramount in this population. Distinguishing severe LV dysfunction caused by thinned, infarcted myocardium with fibrosis and scarring from that due to viable but dysfunctional myocardium from chronic hypoperfusion has significant implications for clinical management. In patients in whom noninvasive testing identifies viability, undergoing revascularization improves outcomes. Noninvasive imaging techniques used to assess viable myocardium are based on demonstrating the presence of one or more of the following features: (1) contractile reserve; (2) sufficient perfusion for the delivery of substrates and removal of metabolic byproducts; (3) intact myocyte membranes to maintain ionic/electrochemical gradients; and (4) preserved metabolism with generation of high-energy phosphates. While nuclear and dobutamine echocardiography have been widely used for viability assessment, cardiac magnetic resonance imaging (CMR) is increasingly becoming an accepted clinical tool, particularly in light of its high spatial resolution, intrinsic ability to image 3-dimensionally, and greater soft tissue differentiation. Moreover, the versatility of the technique potentially allows for the simultaneous assessment of regional wall motion, perfusion, and metabolism. An overview of the CMR techniques is presented.

UR - http://www.scopus.com/inward/record.url?scp=33344460971&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33344460971&partnerID=8YFLogxK

U2 - 10.1053/j.sult.2005.11.001

DO - 10.1053/j.sult.2005.11.001

M3 - Article

VL - 27

SP - 11

EP - 19

JO - Seminars in Ultrasound, CT and MRI

JF - Seminars in Ultrasound, CT and MRI

SN - 0887-2171

IS - 1

ER -